The modern world has been heavily changed since the onset of the COVID-19 outbreak late last year and earlier this year worldwide. While it has negatively affected a lot of businesses worldwide, it has resulted in a great boost to the medical and healthcare research fields, and it is now providing a great opportunity for investors to fund projects that will further humankind’s understanding and ability to combat infectious diseases and other ailments. Where does an investor find and seize such opportunities as have been afforded them in the COVID-19 era, though?
Online Innovation Roadshow
At the onset of a worldwide outbreak of the COVID-19 virus, it was necessary for connections to be rapidly made between investors, the healthcare industry, and medical researchers in order to boost the funding available for combatting the highest infection, as well as to supplement the care aspects of the healthcare industry. To fill the space needed, MyBioGate launched a new project partnering initiative to help China fight the pandemic, but also to provide connective resources worldwide between research and healthcare facilities. Through a select committee made up of 85 people from China and worldwide institutes, including the National Medical Products Administration (NMPA), the National Clinical Laboratories, professors from Wuhan Institute of Virology and other domestic and international universities, and scientists from MNC, antiviral drug research and development was initiated. Projects were selected for an online roadshow to connect them with investors to fund research and development efforts.
2020 China Focus Online Roadshow
So far this year, there have been 10 online roadshows that have been organized, with a showcase of 25 committee-selected projects that are highly promising in the medical and healthcare research fields. These roadshows are occurring between the months of May and July, so there are still several opportunities available for investors to connect to these very promising projects and assist in their funding. From the roadshows already completed, over 1,400 Chinese business partners were attracted, which led to more than 40 companies participating in further collaborative conversations. The projects included in the 2020 China Focus Online Roadshow come from more than 20 countries, resulting in a high level of cross-border cooperation. Throughout the entire roadshow, a total of 40 high-quality projects will be showcased in the complimentary online roadshows to China.
Opportunities to Seize
This has never been a better time for investing in medical and healthcare projects in China and around the world. To meet the demands for these opportunities, MyBioGate has partnered with Jiangsu Industrial Technology Research Institute (JITRI), as well as numerous industrial parks and corporations, to put out the call to companies and medical and healthcare investors to join the 2020 China Focus Online Roadshow and check out the investment opportunities for themselves. The July online roadshows will focus on biomedical innovation materials and high-end medical imaging equipment that is in high demand for the treatment of COVID-19 patients, as well as in most other areas of healthcare and medical research. Through each project’s 25-minute free presentation and 5-minute Q&A, you’ll be given all the information you need to make an informed decision. Connecting to projects that interest you and your company for investing couldn’t be easier through the roadshow, giving you access to projects you may otherwise have been unaware of.
The COVID-19 era has made available investment opportunities that cannot be missed in the medical research and healthcare fields. Be sure to attend the 2020 China Focus Online Roadshow to connect with projects, companies, and other investors. Click here to learn more.